发明名称 COMBINATION OF LOCAL AND SYSTEMIC IMMUNOMODULATIVE THERAPIES FOR ENHANCED TREATMENT OF CANCER
摘要 <p>A method for the treatment of cancer comprising administration of a therapeutically effective amount of an intralesional chemoablative pharmaceutical composition, or variant of said composition, in combination with a therapeutically effective amount of a systemic immunomodulatory anticancer agent. A further method for the treatment of cancer comprising administration of a therapeutically effective amount of an intralesional chemoablative pharmaceutical composition, or variant of said composition, in combination with a therapeutically effective amount of a systemic targeted anticancer agent. The present invention is further directed to pharmaceutical compositions for treatment of cancer. The intralesional chemoablative pharmaceutical composition can comprise an IL chemoablative agent comprising primarily a halogenated xanthene.</p>
申请公布号 KR20140038382(A) 申请公布日期 2014.03.28
申请号 KR20137026664 申请日期 2012.03.09
申请人 PROVECTUS PHARMACEUTICALS, INC.;PFIZER INC. 发明人 EAGLE CRAIG J.;DEES H. CRAIG;WACHTER ERIC A.;SINGER JAMIE
分类号 A61K31/352;A61K39/395;A61P35/00 主分类号 A61K31/352
代理机构 代理人
主权项
地址